Data through FY2026 Q3 (Jun 30, 2026)
Oppenheimer & Co. Inc.
Company profile for Oppenheimer & Co. Inc. covers 11 filings across the reporting window. No certified median available for FY2026.
- FY2026 certified median
- Unavailable
- Total filings
- 11
- FY2026 25th–75th percentile
- Unavailable
- Top job title
- Director, Equity Research
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 7 | $113,000 | $94,350 | $132,866 |
| FY2025 | 3 | $115,731 | $105,366 | $136,866 |
| FY2026 (Q1–Q3) | 1 | Unavailable | Unavailable | Unavailable |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Director, Equity Research2 filings
- Research Associate, Biotechnology2 filings
- AML Testing & Model Validation Analyst1 filings
- Analyst1 filings
- Associate, Healthcare Investment Banking1 filings
- Counsel1 filings
- Equity Research Associate, Exchanges & Information Analytics1 filings
- Equity Research Associate, Portfolio & Electronic Trading1 filings
- Investment Banking Associate1 filings
Top cities
- New York11 filings